Acorah Software Products - Accounts Production19.2.450truetrue31 March 20251 April 2024falsetrueNo description of principal activity1 April 202531 March 202631 March 202612421947C Macauiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure124219472025-03-31124219472026-03-31124219472025-04-012026-03-3112421947frs-bus:PrivateLimitedCompanyLtd2025-04-012026-03-3112421947frs-bus:FilletedAccounts2025-04-012026-03-3112421947frs-bus:Micro-entities2025-04-012026-03-3112421947frs-bus:EntityHasNeverTraded2025-04-012026-03-3112421947frs-bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3112421947frs-bus:Director12025-04-012026-03-31124219472024-03-31124219472025-03-31124219472024-04-012025-03-31
Registered number: 12421947
Dr. Macau Ltd
Unaudited Dormant Financial Statements
For The Year Ended 31 March 2026
Coman & Co Ltd
Dr. Macau Ltd
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 12421947
2026
2025
£
£
Current assets
95,240
95,240
NET CURRENT ASSETS
95,240
95,240
TOTAL ASSETS LESS CURRENT LIABILITIES
95,240
95,240
NET ASSETS
95,240
95,240
CAPITAL AND RESERVES
95,240
95,240
Notes
1.General Information
Dr. Macau Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12421947. The registered office is 124 City Road, London, EC1V 2NX.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
--
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.